Recruiting
Phase 2

Spironolactone for Pulmonary Arterial Hypertension

Sponsor:

NIH

Code:

NCT01712620

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information